These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10488711)

  • 1. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.
    Grando-Lemaire V; Guettier C; Chevret S; Beaugrand M; Trinchet JC
    J Hepatol; 1999 Sep; 31(3):508-13. PubMed ID: 10488711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.
    Nalpas B; Driss F; Pol S; Hamelin B; Housset C; Brechot C; Berthelot P
    J Hepatol; 1991 Jan; 12(1):70-4. PubMed ID: 1848875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
    Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
    Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV genotypes in patients with liver disease of different stages and severity.
    Mangia A; Cascavilla I; Lezzi G; Spirito F; Maertens G; Parlatore L; Saracco G; Rizzetto M; Andriulli A
    J Hepatol; 1997 Jun; 26(6):1173-8. PubMed ID: 9210601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
    Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
    J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
    Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
    Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.
    Terada T; Terasaki S; Nakanuma Y
    Cancer; 1993 Sep; 72(5):1551-6. PubMed ID: 8394196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in patients without cirrhosis in Italy.
    Giannini EG; Marenco S; Bruzzone L; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
    Dig Liver Dis; 2013 Feb; 45(2):164-9. PubMed ID: 23047000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants.
    Le Bail B; Bernard PH; Carles J; Balabaud C; Bioulac-Sage P
    J Hepatol; 1997 Nov; 27(5):835-42. PubMed ID: 9382971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.
    Hellerbrand C; Hartmann A; Richter G; Knöll A; Wiest R; Schölmerich J; Lock G
    Dig Dis; 2001; 19(4):345-51. PubMed ID: 11935095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression in hepatocellular carcinoma in Greece. Correlation with epidemiological and histopathological data.
    Skopelitou A; Hadjiyannakis M; Alexopoulou V; Kamina S; Krikoni O; Agnantis NJ
    Pathol Res Pract; 1996 Nov; 192(11):1100-6. PubMed ID: 9122028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases.
    Bralet MP; Régimbeau JM; Pineau P; Dubois S; Loas G; Degos F; Valla D; Belghiti J; Degott C; Terris B
    Hepatology; 2000 Aug; 32(2):200-4. PubMed ID: 10915724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
    Bruix J; Barrera JM; Calvet X; Ercilla G; Costa J; Sanchez-Tapias JM; Ventura M; Vall M; Bruguera M; Bru C
    Lancet; 1989 Oct; 2(8670):1004-6. PubMed ID: 2572739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
    Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
    Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.